ACE2 and early-onset autosomal dominant Alzheimer disease: Even in Alzheimer’s brains, COVID-19 decreased the protein expression of ACE2, but only to a level that was higher than in the brains of COVID-19 patients without Alzheimer’s disease (Panel (d)).